X Line Objective Lenses Break Optical Barriers with Simultaneously Improved Image Flatness, Chromatic Aberration Correction and Numerical Aperture

Designed with new manufacturing technology that creates lenses with shapes that are difficult to fabricate using other methods, Olympus’ new X Line™ series objectives and the UPLAPO-HR objectives for super resolution and TIRF microscopy break optical barriers to deliver outstanding image quality.

X Line Objective Lenses Break Optical Barriers with Simultaneously Improved Image Flatness, Chromatic Aberration Correction and Numerical Aperture

It is difficult to improve one area of an objective lens, such as numerical aperture, without tradeoffs in another area, like chromatic aberration correction. However, X Line objectives overcome the common tradeoffs by simultaneously improving optical performance in three critical areas:

  • Expanded flatness for uniform images from the center to the edge with an observation area of 1.7 times greater than conventional objectives
  • Exceptional color accuracy during brightfield and multicolor fluorescence imaging with chromatic aberration from violet to near-infrared (400–1000 nm)
  • Excellent image quality, even with weak excitation light, with a higher numerical aperture (up to 1.45) for reduced fluorescence fading and phototoxicity during time-lapse experiments

    With these advancements, users can acquire bright, high-quality images throughout the entire field of view, helping improve quantitative data acquisition and the speed of creating large, stitched images. For pathologists who frequently work with stained samples, accurate color reproduction improves image reliability.

Using the same technology as the X Line series, the UPLAPO-HR super resolution and TIRF objectives are the first plan apochromat objectives in the world to achieve a numerical aperture of 1.5, enabling bright, high-resolution observations of even weak excitation light. During super resolution imaging, these objectives enable users to locate an object of interest using a wider field of view and then smoothly resolve down to a higher magnification.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation - Life Sciences. (2019, June 21). X Line Objective Lenses Break Optical Barriers with Simultaneously Improved Image Flatness, Chromatic Aberration Correction and Numerical Aperture. News-Medical. Retrieved on October 12, 2024 from https://www.news-medical.net/news/20190621/X-Line-objective-lenses-break-optical-barriers-with-simultaneously-improved-image-flatness-chromatic-aberration-correction-and-numerical-aperture.aspx.

  • MLA

    Evident Corporation - Life Sciences. "X Line Objective Lenses Break Optical Barriers with Simultaneously Improved Image Flatness, Chromatic Aberration Correction and Numerical Aperture". News-Medical. 12 October 2024. <https://www.news-medical.net/news/20190621/X-Line-objective-lenses-break-optical-barriers-with-simultaneously-improved-image-flatness-chromatic-aberration-correction-and-numerical-aperture.aspx>.

  • Chicago

    Evident Corporation - Life Sciences. "X Line Objective Lenses Break Optical Barriers with Simultaneously Improved Image Flatness, Chromatic Aberration Correction and Numerical Aperture". News-Medical. https://www.news-medical.net/news/20190621/X-Line-objective-lenses-break-optical-barriers-with-simultaneously-improved-image-flatness-chromatic-aberration-correction-and-numerical-aperture.aspx. (accessed October 12, 2024).

  • Harvard

    Evident Corporation - Life Sciences. 2019. X Line Objective Lenses Break Optical Barriers with Simultaneously Improved Image Flatness, Chromatic Aberration Correction and Numerical Aperture. News-Medical, viewed 12 October 2024, https://www.news-medical.net/news/20190621/X-Line-objective-lenses-break-optical-barriers-with-simultaneously-improved-image-flatness-chromatic-aberration-correction-and-numerical-aperture.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Olympus announces first results of its AI-based pathology diagnostic tool for gastric cancer